Protocols: Preventive Treament of Degenerative Diseases and Integrative Cell Regeneration

Anti-Aging Medicine, Endocrinologists, Gynecologists, Urologists, Geriatricians, Internal Medicine, Plastic Surgeons, General Medicine (All Specialties).

Cell Therapy is one of the most complete biological therapies for regenerative processes at the cellular level. Cell therapy describes the process of introducing new cells into a tissue in order to treat a disease. Cell therapy is commonly focused on genetic diseases, with or without the help of gene therapy.

Cell Therapy or Stem Cell Therapy is the process by which new stem cells, or cells of a specific tissue or organ, are introduced into the body in order to produce the effect of regeneration and general revitalization, or to treat a disease. The process for all types of Cell Therapy begins with the selection of the stem cells or cells from specific organs.

Cell therapy with Pluripotent Stem Cell extracts produces a general revitalization and rejuvenation in the body, maintains health and lengthens life, effectively stimulates the cells of specific organ systems related to obesity, arthritis, chronic fatigue, asthma, degenerative brain diseases, osteoporosis, blood flow alterations, sexual dysfunction, male impotence, diabetes mellitus, hormonal changes, skin outbreaks, and many other metabolic diseases. With regard to esthetics, the skin on both the face and body will look younger and healthier in terms of texture and color. Your body will be in shape and more flexible.

Antioxidant-rich Antioxidant Therapy prevents, or at the very least, reduces, organic functional deterioration caused by an excess of oxidative stress.

We can assert that free radicals and the oxidative stress they cause are clearly involved in the etiopathology of different diseases, some of which are of great significance among the population, such as atherosclerosis, cancer, hypertension, etc.

The recommendation to consume antioxidants is very effective to prolong survival and reduce certain pathologies.
Several risk factors have been associated with the development of cardiovascular and degenerative diseases. Among these is oxidative stress, which leads to elevated concentrations of the end-products of lipid peroxidation.

A lower incidence of degenerative diseases has been found in people who have begun to increase their consumption of antioxidants, which neutralize free radicals. Thus, antioxidants perform a fundamental function in the prevention of these diseases and in achieving a positive effect on public health.

Protocol 1 (Cellular Regeneration)

• Human-Ultracell V

• For ages between 30 and 45: administer one round of treatment per year. • For ages between 46 and 60: administer 2 rounds of treatment per year, one monthly, 2 continuous months, composed of 2 boxes of 4 vials, (8 vials) adminis-tered over 8 continuous weeks until the completion of 8 injections. • After 61 years of age, administer three rounds of treatment each year, one per month, composed of three boxes of 4 vials, (12 vials), administered over 12 contin-uous weeks until completing 12 injections.

• Human-Citoplacell 3G

To be administered concurrently with Human Ultracell V treatment, one white capsule at morning, one red capsule at night, before meals, continuously during 6 months and evalu-ate.

• Human-Ultracell V (Reinforment)

After 6 months administering Human-Ultracell V, it is recommendable to administer one application of Human-Ultracell V single dose as reinforcement to the treatment applied 6 months before, to have an integral treatment.

• For individuals of both sexes from 30 to 45 years old, 1 treatment of Human-Ultracell V is administered, AS A SINGLE DOSE 6 months after the application of Human-Ultracell V.
• For individuals of both sexes from 46 and 60 years old, apply 2 individual doses of Human-Ultracell V, as independent dose, 6 months after the treatment with Human-Ultracell V, once per week for 2 weeks.
• For individuals of both sexes 61 and over, administer 3 individual doses of Human-Ultracell V, as independent dose, 6 months after the application of the treatment with Human-Ultracell V, once per week for 3 weeks.

In all cases, for the length of the treatment with Human-Ultracell V by injection, Revercell should be taken daily.

• Revercell

To be administered concurrently with Human-Ultracell V. One white capsule at morning, one white/red capsule during afternoon and one red capsule at night before meals, during 6 months and re-evaluate.

Protocol 2 (cellular renovation)

• Human-Ultracell V

• For ages 30 to 45: administer one round of treatment per year. Administer over 4 continuous weeks, one injection per week until completing 4 injections.
• From ages 46 to 60: administer 2 rounds of treatment per year, one monthly, 2 continuous months, composed of 2 boxes of 4 vials, (8 vials) administered over 8 continuous weeks until completing 8 injections.
• After 61 years of age, administer three rounds of treatment each year, one per month, composed of three boxes of 4 vials, (12 vials), administered over 12 con-tinuous weeks until completing 12 injections.

In all cases must be completed daily with Revercell and Human-Citoplacell 3G, together during the injectable treatment.

• Human-Citoplacell 3G

To be administered with Human-Ultracell V and Revercell. Take one white capsule at morning, one red capsule at night before food, for suitable results, during all year and re-evaluate.

• Human-Ultracell V (Reinforment)

After 6 months of treatment with Human-Ultracell V, it is recommended one application of Human-Ultracell V (single dose) as reinforcement for the treatment applied 6 months be-fore, to get a complete treatment.

• For individuals of both sexes from 30 to 45 years old: administer one individual dose of Human-Ultracell V, AS SINGLE DOSE, 6 months after administering the complete treatment of Human-Ultracell V.
• For individuals of both sexes from 46 to 60 years old: administer 2 individual doses of Human-Ultracell V, as independent dose, 6 months after finished the complete treatment of Human-Ultracell V, once a week during 2 weeks.
• For individuals of both sexes from 61 and over: administer 3 treatments each year. Administer 3 individual doses of Human-Ultracell V, as independent dose, 6 months after applying the complete treatment of Human-Ultracell V, once a week during 3 weeks.

In all cases should be completed daily with Revercell and Human-Citoplacell 3G, together during the injectable treatment of Human-Ultracell V.

• Revercell

To be administered concurrently with Human-Ultracell V. One white capsule at morning, one white/red capsule during afternoon and one red capsule at night before meals, Treatment should be taken for one year, and then re-evaluate.